These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10491422)

  • 1. Stem cell maneuvers target bone marrow toxicity.
    Randal J
    J Natl Cancer Inst; 1999 Sep; 91(18):1530-2. PubMed ID: 10491422
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful mobilisation of blood stem cells following previous autologous bone marrow transplantation.
    McQuaker IG; Haynes AP; Iqbal A; Russell NH
    Bone Marrow Transplant; 1996 Jul; 18(1):263-4. PubMed ID: 8832036
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemoprotection with dicarbamine: shielding of bone marrow hemopoietic cells from apoptosis and induction of cell differentiation in myelosuppressive effect of cyclophosphamide].
    Raĭkhlin NT; Bukaeva IA; Sitdikova SM; Nebol'sin VE
    Vopr Onkol; 2011; 57(4):497-500. PubMed ID: 22191241
    [No Abstract]   [Full Text] [Related]  

  • 4. [Autologous bone marrow grafts and solid tumors].
    Beaulieu R
    Union Med Can; 1983 May; 112(5):450-2, 460. PubMed ID: 6349082
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of BCNU combined with total body irradiation or cyclophosphamide on survival of dogs after autologous marrow grafts.
    Paterson AH; English D
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1585-7. PubMed ID: 395139
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantation.
    Comenzo RL; Hassoun H; Kewalramani T; Klimek V; Dhodapkar M; Reich L; Teruya-Feldstein J; Fleisher M; Filippa D; Nimer SD
    Leukemia; 2006 Feb; 20(2):345-9. PubMed ID: 16319952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute coronary syndrome upon receiving carmustine infusion before autologous stem-cell transplantation.
    Waibel Pachinger C; Rosselet A; Berthouzoz S; Luthi F; Ketterer N
    Hematol Oncol; 2012 Dec; 30(4):216-8. PubMed ID: 22287477
    [No Abstract]   [Full Text] [Related]  

  • 8. A single prior course of BCNU-cisplatin chemotherapy has a significant deleterious effect on mobilization kinetics of otherwise untreated patients.
    Pérez-Calvo J; Fernàndez O; Aristu JJ; Aramendia JM; Rifón J; Prosper F; Bendandi M; Rocha E; Martin-Algarra S
    Bone Marrow Transplant; 2004 Mar; 33(5):499-502. PubMed ID: 14716344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloprotection with drug-resistance genes.
    Banerjee D; Bertino JR
    Lancet Oncol; 2002 Mar; 3(3):154-8. PubMed ID: 11902501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone marrow transplantation in radiation and chemotherapy].
    Baisogolov GD; Zhukovskii IIa
    Vopr Onkol; 1972; 18(10):89-100. PubMed ID: 4145691
    [No Abstract]   [Full Text] [Related]  

  • 11. Headache, circumoral paresthesia, and facial flushing associated with high-dose carmustine infusion.
    Woo MH; Ippoliti C; Bruton J; Mehra R; Champlin R; Przepiorka D
    Bone Marrow Transplant; 1997 Apr; 19(8):845-7. PubMed ID: 9134180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of breast cancer: a pilot trial.
    Deisseroth AB; Holmes F; Hortobagyi G; Champlin R
    Hum Gene Ther; 1996 Feb; 7(3):401-16. PubMed ID: 8835224
    [No Abstract]   [Full Text] [Related]  

  • 14. High-dose BCNU with ABMT followed by radiation therapy in the treatment of supratentorial glioblastoma multiforme.
    Linassier C; Benboubker L; Velut S; Calais G; Saudeau D; Jan M; Autret A; Berger C; Biron P; Colombat P
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S69-72. PubMed ID: 8899180
    [No Abstract]   [Full Text] [Related]  

  • 15. Does high-dose carmustine increase overall survival in supratentorial high-grade malignant glioma? An EBMT retrospective study.
    Bay JO; Linassier C; Biron P; Durando X; Verrelle P; Kwiatkowski F; Rosti G; Demirer T;
    Int J Cancer; 2007 Apr; 120(8):1782-6. PubMed ID: 17230505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanisms involved in the impairment of hematopoiesis after autologous bone marrow transplantation.
    Domenech J; Roingeard F; Binet C
    Leuk Lymphoma; 1997 Jan; 24(3-4):239-56. PubMed ID: 9156654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper lobe pulmonary fibrosis associated with high-dose chemotherapy containing BCNU for bone marrow transplantation.
    Parish JM; Muhm JR; Leslie KO
    Mayo Clin Proc; 2003 May; 78(5):630-4. PubMed ID: 12744552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced breast cancer: high-dose chemotherapy and bone marrow autotransplants.
    Antman K; Gale RP
    Ann Intern Med; 1988 Apr; 108(4):570-4. PubMed ID: 3279894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects for eradication of therapy-induced myelosuppression.
    Ventura G; Spitzer G; Hester J; Deisseroth A
    Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():41-2. PubMed ID: 1969309
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination chemotherapy in disseminated testicular cancer: the Indiana University experience.
    Einhorn LH; Donohue JP
    Semin Oncol; 1979 Mar; 6(1):87-93. PubMed ID: 88074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.